Dr. Reddy's in talks to buy UCB's Indian biz; Boehringer loses Indian patent on COPD med Spiriva;

@FiercePharma: Bayer puts cancer-fighting country crooner onstage to promote colonoscopies. FiercePharmaMarketing article | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI: GSK sacks 100-plus China workers for misconduct in wake of bribery scandal. Report | Follow @CarlyHFierce

> India's Dr. Reddy's is said to be in talks to buy Belgium-based UCB's Indian operations for $135 million. Report

> Germany's Boehringer Ingelheim lost its Indian patent on the lung drug Spiriva, as the country's patent office sided with Cipla in a patent challenge. Report

> Sanofi ($SNY) tapped Robert Castaigne to chair its audit committee, replacing Dr. Klaus Pohle, who'll remain on the board; Castaigne, who was Total's CFO till 2008, has served as a Sanofi director since 2000. Release

> Portola Pharmaceuticals, which is developing an antidote to a new generation of anticoagulant drugs, expects to raise $100 million in a stock offering priced Tuesday. Release

> The FDA released new documents to provide a roadmap for companies developing generic versions of 38 drugs, including newer meds Kalydeco, from Vertex Pharmaceuticals ($VRTX), and Imbruvica, sold by Johnson & Johnson ($JNJ) and Pharmacyclics ($PCYC). Report

> Actavis ($ACT) rolled out its generic version of Temovate, a topical steroid marketed by Fougera. Report

Medical Device News

@FierceMedDev: Exact Sciences signs on Anthem and Aetna to noninvasive colon cancer Dx. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: FDA approves novel blood purifier that treats rare condition in hemodialysis patients. Report | Follow @VarunSaxena2

@EmilyWFierce: Check out FierceBiotech Radio's latest podcast with Express Scripts CMO Steve Miller on iTunes. | Follow @EmilyWFierce

> Veniti raises $17M to complete pivotal venous stent trial aimed at FDA approval. News

> Apple announces open-source data-collection platform for mobile medical apps. Story

> Study: FDA-cleared biomarker can reduce ADHD overdiagnosis. Article

Biotech News

@FierceBiotech: FierceBiotech Radio with Express Scripts' Steve Miller. More | Follow @FierceBiotech

@JohnCFierce: Biopharma's new normal: Constant makeovers leave R&D jobs at permanent risk. Editor's corner | Follow @JohnCFierce

@DamianFierce: Hey @FierceBiotech's podcast is now available on Stitcher. If you know what that means, here you go. | Follow @DamianFierce

> Collegium bags $50M to get its abuse-deterrent painkiller through the FDA. News

> FDA panel backs Kythera's double chin-fighting shot. Story

> Eyeing an FDA filing, Ocular Therapeutix drug hits PhIIIa goals. Article

Biotech Research News

> Mouse model for rheumatoid arthritis responds to M-MDSCs. Item

> Salk scientists use new CRISPR tech to chop up HIV. More

> Activating thyroid hormone receptor may rev up metabolism. Story

> UC Berkeley team puts its heart into latest organ-on-a-chip project. Article

> Mayo/Scripps team begins testing a new class of anti-aging drugs. Report

Pharma Manufacturing News

> Sun's buyout of Ranbaxy gets India's approval. Item

> U.S. biotech buying Belgium cell manufacturer for $25M. News

> Hospira recalls more saline as well as drug used during pregnancy. Report

> Patheon strikes again; deal for Agere its second in a week. Story

> Recro picks up Alkermes plant, pain drugs and contract biz. Article

Pharma Asia News

> Boehringer Spiriva patent revoked in Cipla challenge in India. Item

> SK Chemicals gets Korea nod for cell-culture flu vaccine 'SKYCellflu.' Report

> Japan's R-Tech Ueno evaluates options as PhIII candidate Unoprostone fails primary endpoint. More

> Sun and Ranbaxy now a couple as last hurdle cleared for India's top drug company. Story

> Sri Lanka poised to launch mandatory generics-first policy. Article

And Finally... A growing number of breast cancer patients are freezing their scalps to preserve their hair during chemo treatment. Report